Doximity (DOCS) Price Target Lowered by JP Morgan | DOCS Stock News

Author's Avatar
May 27, 2025

On May 27, 2025, analyst Anne Samuel from JP Morgan provided an updated analysis on Doximity (DOCS, Financial). The firm maintained its 'Neutral' rating for the stock, reflecting the same stance as prior evaluations.

However, JP Morgan adjusted its price target for Doximity (DOCS, Financial) from $63.00 to $60.00 USD, marking a decrease of approximately 4.76%. This update highlights the revised outlook on the company's potential share price in the coming months.

The current evaluation follows Doximity's continuous performance on the NYSE, with the analyst's insights serving as a critical indicator for investors assessing potential changes in investment strategies related to the stock.

Wall Street Analysts Forecast

1927366120277438464.png

Based on the one-year price targets offered by 17 analysts, the average target price for Doximity Inc (DOCS, Financial) is $61.47 with a high estimate of $88.00 and a low estimate of $50.00. The average target implies an upside of 18.18% from the current price of $52.02. More detailed estimate data can be found on the Doximity Inc (DOCS) Forecast page.

Based on the consensus recommendation from 20 brokerage firms, Doximity Inc's (DOCS, Financial) average brokerage recommendation is currently 2.4, indicating "Outperform" status. The rating scale ranges from 1 to 5, where 1 signifies Strong Buy, and 5 denotes Sell.

Based on GuruFocus estimates, the estimated GF Value for Doximity Inc (DOCS, Financial) in one year is $54.26, suggesting a upside of 4.32% from the current price of $52.015. GF Value is GuruFocus' estimate of the fair value that the stock should be traded at. It is calculated based on the historical multiples the stock has traded at previously, as well as past business growth and the future estimates of the business' performance. More detailed data can be found on the Doximity Inc (DOCS) Summary page.

Disclosures

I/We may personally own shares in some of the companies mentioned above. However, those positions are not material to either the company or to my/our portfolios.